One of the exercises was to map "Real-World" experiences to the development pathway.
And, once again, the group traced the root cause of failures in the development life cycle for new medical devices to misconceptions at the START of the development pathway.
The technology rarely fails for technical reasons.
Instead most new technologies fail because they meet a need that does not exist, based on a patient pathway that does not exist, delivering uncertain benefits, without thought of the adoption pathway, at a price that nobody will pay.
And this is odd. Because we can start to address most of these issues from project inception. Before development becomes very expensive, Ahead of the clinical trials.
Despite reviews by funders, despite due diligence reviews by venture capitalists, it is amazing how far along the development pathway a device can travel before it is finally canned. Optimism bias and a charismatic champion can take a failing product a long way.
Technology fails for business reasons - not technical reasons.